Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia
Clinical trial NCT07723716 · COMPLETED
Trial details
- NCT number
- NCT07723716
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-26
- Primary completion
- 2025-09-25
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.